Next-generation regulatory T cell therapy

Overview of attention for article published in Nature Reviews Drug Discovery, September 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
Good Attention Score compared to outputs of the same age and source (74th percentile)

So far, Altmetric has seen 139 X posts from 101 X users, with an upper bound of 346,930 followers.

RT @NatRevDrugDisc: For readers interested in next-generation therapeutics based on regulatory T cells, here's a review from Jeffrey Bluest…

RT @NatRevDrugDisc: For readers interested in next-generation therapeutics based on regulatory T cells, here's a review from Jeffrey Bluest…

RT @NatRevDrugDisc: For readers interested in next-generation therapeutics based on regulatory T cells, here's a review from Jeffrey Bluest…

RT @NatRevDrugDisc: For readers interested in next-generation therapeutics based on regulatory T cells, here's a review from Jeffrey Bluest…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 135 additional X posts.